Crossmark

Assessment of effectiveness and safety of repeat administration of proinflammatory primed allogeneic mesenchymal stem cells in an equine model of chemically induced osteoarthritis

Crossref DOI link: https://doi.org/10.1186/s12917-018-1556-3

Published Online: 2018-08-17

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Barrachina, Laura

Remacha, Ana Rosa

Romero, Antonio

Vitoria, Arantza

Albareda, Jorge

Prades, Marta

Roca, Mercedes

Zaragoza, Pilar

Vázquez, Francisco José

Rodellar, Clementina http://orcid.org/0000-0003-3289-2675
Funding

Funding for this research was provided by:

Ministerio de Economía y Competitividad (AGL2011-28609)

Gobierno de Aragón (A17-LAGENBIO, Doctoral grant)

Universidad de Zaragoza (Doctoral grant)
License Information

Text and Data Mining valid from 2018-08-17
More Information

Article History

Received: 23 March 2018

Accepted: 26 July 2018

First Online: 17 August 2018

Ethics approval and consent to participate

: All procedures were carried out under Project License (PI 31/11) approved by the Ethic Committee for Animal Experiments from the University of Zaragoza. The care and use of animals were performed in accordance with the Spanish Policy for Animal Protection RD53/2013, which meets the European Union Directive 2010/63 on the protection of animals used for scientific purposes.

: Not applicable

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below